Our Members

Innoviva Specialty Therapeutics, Inc.

About Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., is focused on delivering innovative therapies in critical care and infectious disease. Innoviva Specialty Therapeutics’ products, through its affiliate, La Jolla Pharmaceutical Company, include GIAPREZA® (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA® (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Innoviva Specialty Therapeutics’ products, through its affiliate, Entasis Therapeutics Inc., include XACDURO® (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use approved for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex (Acinetobacter). For more information about Innoviva Specialty Therapeutics, please visit here.
How we share on the Vivli Platform To obtain Innoviva Specialty Therapeutics’ AMR surveillance data for analysis, data requesters should use the AMR Register platform to submit a request. The de-identified data will then be made available to the researcher to download. Data for ongoing surveillance programs will be updated annually.
Studies Listed for Sharing Innoviva Specialty Therapeutics, Inc., an affiliate of Entasis Therapeutics Inc. AMR surveillance data available on the AMR Register:

  • Acinetobacter baumannii-calcoaceticus complex surveillance
Exceptions AMR surveillance data may not be provided in certain situations, including but not limited to:

  • Privacy and confidentiality of participants cannot be protected (data cannot be fully de-identified in such a way as to guarantee the anonymity of the research participants);
  • Where regulatory, legal, contractual or other limitations exist;
  • Limitations in data format and cannot be properly converted to electronic format;
What information will be provided Where available, the following data and information is provided for each dataset:

  • Raw dataset. This is the dataset containing the de-identified isolate level data collected during the study. The dataset can be downloaded.
  • Program description. Information about how the data were collected are provided on the program pages.
  • Links to Publications. Links to journal publications based on the data collected are provided on the program pages.
Questions or enquiries Please send any questions or enquiries to amr@vivli.org
Data Request Review Process Researchers can request access to our datasets by completing a data request form on the AMR register. The datasets can be downloaded.
Pursuant to the US DOJ Final Rule – Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern (28 CRF Part 202)

  • Requests from Countries of Concern or Covered Persons for accessing all datasets, including those with sensitive personal data of US persons, will be declined.
Clinical Study Register or Website For more information about Innoviva Specialty Therapeutics, please visit here.
Back to Our Members